NATURE’S SUNSHINE PRODUCTS, INC. Proceeds from Related Party Debt
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Proceeds from Related Party Debt of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRelatedPartyDebt · last filed 2020-03-11
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from related party debt for the quarter ending 2019-12-31 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from related party debt for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from related party debt for the quarter ending 2019-06-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from related party debt for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from related party debt for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from related party debt for fiscal 2018 was $1.00M, a 97.63% increase from fiscal 2017.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from related party debt for fiscal 2017 was $506.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. proceeds from related party debt for fiscal 2016 was $0.00.
| Period end | Proceeds from Related Party Debt 3 month | Proceeds from Related Party Debt 6 month | Proceeds from Related Party Debt 9 month | Proceeds from Related Party Debt 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $0.00 10-K · filed 2020-03-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | $0.00 derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | $0.00 derived: sum of 3 quarters · filed 2020-03-11 | $500.00K derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-11 | $500.00K derived: sum of 3 quarters · filed 2020-03-11 | $500.00K derived: sum of 4 quarters · filed 2020-03-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $500.00K derived: sum of 2 quarters · filed 2020-03-11 | $500.00K derived: sum of 3 quarters · filed 2020-03-11 | $1.00M 10-K · filed 2020-03-11 |
| 2018-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $500.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.00M 10-Q · filed 2019-11-07 | $1.01M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $500.00K 10-Q · filed 2019-08-09 | $506.00K derived: sum of 3 quarters · filed 2019-08-09 | $1.01M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $500.00K 10-Q · filed 2019-05-09 | $506.00K derived: sum of 2 quarters · filed 2019-05-09 | $1.01M derived: sum of 3 quarters · filed 2019-05-09 | $1.01M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $506.00K derived: sum of 2 quarters · filed 2019-03-08 | $506.00K derived: sum of 3 quarters · filed 2019-03-08 | $506.00K 10-K · filed 2019-03-08 |
| 2017-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $500.00K derived: sum of 2 quarters · filed 2018-11-08 | $500.00K 10-Q · filed 2018-11-08 | $500.00K derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | $0.00 derived: sum of 3 quarters · filed 2019-03-08 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | $0.00 derived: sum of 2 quarters · filed 2019-03-08 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $0.00 10-K · filed 2019-03-08 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |